PBE Holdings Information

PBE is an equity ETF with a total of 32 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 5.31%, Biogen at 5.10%, Amgen at 5.04%, Illumina at 5.03%, and United Therapeutics at 5.02%.

Total Holdings

Top 10 Percentage

45.82%

Asset Class

Equity

ETF Category

Health

Assets

258.83M

PE Ratio

18.50

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ALNY	Alnylam Pharmaceuticals, Inc.	5.31%	29,494
2	BIIB	Biogen Inc.	5.10%	72,430
3	AMGN	Amgen Inc.	5.04%	38,293
4	ILMN	Illumina, Inc.	5.03%	101,676
5	UTHR	United Therapeutics Corporation	5.02%	26,838
6	GILD	Gilead Sciences, Inc.	4.85%	102,236
7	REGN	Regeneron Pharmaceuticals, Inc.	4.70%	16,819
8	INCY	Incyte Corporation	4.68%	120,549
9	BCRX	BioCryst Pharmaceuticals, Inc.	3.10%	1,022,796
10	MNKD	MannKind Corporation	3.01%	1,361,734
11	ACAD	ACADIA Pharmaceuticals Inc.	3.00%	292,289
12	NBIX	Neurocrine Biosciences, Inc.	2.95%	49,456
13	EXEL	Exelixis, Inc.	2.84%	165,342
14	IONS	Ionis Pharmaceuticals, Inc.	2.81%	88,967
15	COLL	Collegium Pharmaceutical, Inc.	2.81%	153,076
16	VCYT	Veracyte, Inc.	2.74%	149,587
17	FOLD	Amicus Therapeutics, Inc.	2.72%	706,339
18	TECH	Bio-Techne Corporation	2.70%	110,028
19	MDGL	Madrigal Pharmaceuticals, Inc.	2.69%	11,882
20	QGEN	Qiagen N.V.	2.69%	147,939
21	PTGX	Protagonist Therapeutics, Inc.	2.69%	79,664
22	RGEN	Repligen Corporation	2.68%	41,766
23	RPRX	Royalty Pharma plc	2.66%	175,741
24	CPRX	Catalyst Pharmaceuticals, Inc.	2.65%	296,898
25	TGTX	TG Therapeutics, Inc.	2.65%	218,099

Showing 25 of 32 holdings

Subscribe to see the full list

Activate Now

As of Dec 4, 2025